# Laryngeal metastasis from a thumb melanoma after a 5-year disease-free interval: A case of acute airway presentation and review of the literature

**Authors:** Achraf Amine Sbai, Issam Berrajaa, Mohamed Bouallou, Drissia Benfadil, Azeddine Lachkar, Fahd El Ayoubi El Idrissi

PMC · DOI: 10.1016/j.radcr.2026.01.093 · Radiology Case Reports · 2026-03-05

## TL;DR

A rare case of melanoma spreading to the larynx after 5 years, treated with surgery and immunotherapy, shows no recurrence after a year.

## Contribution

Highlights the aggressive treatment potential and long-term surveillance needs in oligometastatic melanoma.

## Key findings

- Metastatic melanoma to the larynx was confirmed via histopathology after emergency tracheotomy.
- The patient remained recurrence-free at 1-year follow-up after total laryngectomy and immunotherapy.
- Lifelong surveillance is emphasized for melanoma patients due to delayed metastasis potential.

## Abstract

Metastatic malignant melanoma to the larynx is an exceptionally rare clinical entity. We report the case of a 55-year-old woman with a history of thumb melanoma treated 5 years prior, who presented with laryngeal dyspnea. Imaging revealed a large, non-enhancing laryngeal mass infiltrating all 3 levels, with thyroid cartilage lysis and an ipsilateral metastatic cervical lymph node. Following emergency tracheotomy, histopathology confirmed metastatic melanoma (HMB-45+, Melan-A+). The patient underwent total laryngectomy with bilateral neck dissection, followed by adjuvant nivolumab immunotherapy. At the 1-year follow-up, she shows no evidence of recurrence with good stoma function and manageable immunotherapy-related fatigue. This case highlights the diagnostic challenges, the potential for aggressive curative treatment in oligometastatic disease, and underscores the need for lifelong surveillance in melanoma patients.

## Linked entities

- **Diseases:** melanoma (MONDO:0005105), malignant melanoma (MONDO:0005105)

## Full-text entities

- **Genes:** MLANA (melan-A) [NCBI Gene 2315] {aka MART-1, MART1}
- **Diseases:** Laryngeal metastasis (MESH:D009362), dyspnea (MESH:D004417), malignant melanoma (MESH:D008545), thyroid cartilage (MESH:D002357), fatigue (MESH:D005221)
- **Chemicals:** nivolumab (MESH:D000077594)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12993014/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12993014/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12993014/full.md

---
Source: https://tomesphere.com/paper/PMC12993014